Saforax Ltd.

Saforax (Safe-for-Thorax) is an innovative medical device designed to transform chest drainage procedures, making them accessible at the point of injury, to lower-skilled practitioners, including those in high-stress environments like battlefields. With chest injuries being the second leading cause of preventable death in combat, Saforax addresses a critical need for rapid, safe intervention. The global chest drainage devices market, projected to grow from $1.02 billion in 2024 to $1.74 billion by 2034, while chest drainage complications losses in the U.S. alone are estimated to cost $16.2 billion annually. This underscores the demand for solutions like Saforax. The device simplifies chest tube insertion with intuitive, user-friendly features, enabling EMT-Basics, combat medics, and other lower-trained personnel to perform chest decompression safely and effectively, even with minimal training. Preliminary results indicate that Saforax is safe, even in cases of misdiagnosis, as well as allowing for alternative placement outside traditional anatomical "safe zones." Its minimally invasive design promotes faster recovery, reduces pain, and lowers the risk of infections, potentially decreasing overall healthcare costs. With its standardized, reliable, and cost-effective approach to chest drainage, Saforax aims to set a new benchmark for trauma care and chest tube insertion in both military and civilian settings.